Stock Watch: A Short History Of Placebo Approvals
The FDA Has A Track Record In Approving Placebo-Like Drugs
Executive Summary
Biogen’s recent contentious approval put the cat amongst the pigeons in the debate on surrogate markers as a basis for accelerated approval. The history of such approvals goes back to the last century.